Corcept Therapeutics
CORT · NASDAQ
Bulios Fair Price
$68.81
40.1% downside
Preț actual
$114.86
Potrivit Bulios Fair Price, acțiunile CORT sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Bulios Fair Price este o estimare a valorii corecte a unei acțiuni din modelul de evaluare Bulios. Este un punct de plecare pentru propria analiză, nu o recomandare de investiții. Cum funcționează?
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Despre companie
Corcept Therapeutics Incorporated (CORT) is an American biotechnology company specializing in research, development, and commercialization of drugs for the treatment of endocrine and psychiatric disorders. With activities in biotechnology and pharmacology, Corcept Therapeutics is a key player in the world of innovative treatment approaches. Their research focuses on discovering new treatment methods and therapies for patients with endocrine and psychiatric disorders, including Cushing's syndrome. The company aims to provide modern treatment solutions and improve the quality of life for patients. Corcept Therapeutics is characterized by expertise in pharmacology and endocrine medicine. Corcept Therapeutics Incorporated (CORT) shares could be suitable for investors looking for an investment opportunity in the biotechnology and pharmaceutical sector with a company that specializes in innovative treatment approaches and therapies for patients with endocrine and psychiatric disorders.
Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Joseph K. Belanoff
Employees
730
Headquarters
Redwood City
Evenimente viitoare
Earnings
Upcoming earnings report